These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6789839)

  • 1. Selection of donor platelets for alloimmunized patients using a platelet-associated IgG assay.
    Myers TJ; Kim BK; Steiner M; Baldini MG
    Blood; 1981 Sep; 58(3):444-50. PubMed ID: 6789839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of platelet alloimmunity with a platelet-associated IgG assay.
    Myers TJ; Kim BK; Steiner M; Bishop J; Baldini MG
    J Lab Clin Med; 1981 Jun; 97(6):854-63. PubMed ID: 7014743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suitability of liquid-stored donor platelets in platelet compatibility testing.
    Kiss JE; Salamon DJ; Wilson J; Ramsey G; Duquesnoy RJ
    Transfusion; 1989 Jun; 29(5):405-10. PubMed ID: 2660335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
    Sintnicolaas K; Löwenberg B
    Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet crossmatching with lymphocytotoxicity test: an effective method in alloimmunized Chinese patients.
    Chow MP; Yung CH; Hu HY; Tzeng JL; Lin WM; Lin CK
    Transfusion; 1991 Sep; 31(7):595-9. PubMed ID: 1891789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of in vitro assays in selection of compatible platelet donors.
    Tosato G; Appelbaum FR; Trapani RJ; Dowling R; Deisseroth AB
    Transfusion; 1980; 20(1):47-54. PubMed ID: 7355471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
    Friedberg RC; Donnelly SF; Mintz PD
    Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy.
    Brubaker DB; Romine M
    Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of cross-matching for transfusion of platelet concentrates to alloimmunized recipients.
    Filip DJ; Duquesnoy RJ; Aster RH
    Am J Hematol; 1976; 1(4):471-9. PubMed ID: 1008059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates.
    O'Connell BA; Lee EJ; Rothko K; Hussein MA; Schiffer CA
    Blood; 1992 Jan; 79(2):527-31. PubMed ID: 1730095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of platelet-bound alloantibodies by radioimmunoassay: a study on some variables.
    Vos JJ; Huisman JG; Winkel IN; Risseeuw-Bogaert NJ; Engelfriet CP; von dem Borne AE
    Vox Sang; 1987; 53(2):108-16. PubMed ID: 3686936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet crossmatch tests using radiolabelled staphylococcal protein A or peroxidase anti-peroxidase in alloimmunized patients.
    Yam P; Petz LD; Scott EP; Santos S
    Br J Haematol; 1984 Jun; 57(2):337-47. PubMed ID: 6375714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients.
    Freedman J; Gafni A; Garvey MB; Blanchette V
    Transfusion; 1989; 29(3):201-7. PubMed ID: 2493693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liberation of surface and internal platelet-associated IgG (PA-IgG) during platelet activation.
    Pfueller SL; David R
    Br J Haematol; 1986 Aug; 63(4):785-94. PubMed ID: 3730298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-matching procedure for the selection of platelet donors for alloimmunized patients.
    Waters AH; Minchinton RM; Bell R; Ford JM; Lister TA
    Br J Haematol; 1981 May; 48(1):59-68. PubMed ID: 7018556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of alloimmunization in platelet survival studies.
    Mueller-Eckhardt G; Breidenbach M; Mahn I; Mueller-Eckhardt C
    Blut; 1980 Aug; 41(2):93-9. PubMed ID: 7437528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Random donor platelet crossmatching: comparison of four platelet antibody detection methods.
    Freedman J; Garvey MB; Salomon de Friedberg Z; Hornstein A; Blanchette V
    Am J Hematol; 1988 May; 28(1):1-7. PubMed ID: 3285667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.
    Petz LD; Garratty G; Calhoun L; Clark BD; Terasaki PI; Gresens C; Gornbein JA; Landaw EM; Smith R; Cecka JM
    Transfusion; 2000 Dec; 40(12):1446-56. PubMed ID: 11134563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.